Translational Development Acquisition Stock

Translational Development Acquisition P/B

The P/B (Price-to-Book Ratio) of Translational Development Acquisition (TDAC) as of Aug 20, 2026 is 1.31. In the previous year, P/B (Price-to-Book Ratio) was 1.36 — a change of -3.63% (lower).

P/B

1.31

YoY

-3.63%

Last updated:

P/B (Price-to-Book Ratio) of Translational Development Acquisition is 2026 1.31 . P/B (Price-to-Book Ratio) of Translational Development Acquisition was 2025 1.36 . It decreases by -3.63% lower compared to the previous year.
Access this data via the Eulerpool API

Translational Development Acquisition Stock analysis

What does Translational Development Acquisition do? Translational Development Acquisition is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Translational Development Acquisition stock

P/B (Price-to-Book Ratio) of Translational Development Acquisition is 1.31 in 2026.

P/B (Price-to-Book Ratio) of Translational Development Acquisition changed from 1.36 to 1.31, representing a -3.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Translational Development Acquisition since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Translational Development Acquisition with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Translational Development Acquisition

All Key Metrics — Translational Development Acquisition